awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36946766-3B6E1544-2A55-4BC0-B67A-37B2A034B22F
Q36946766-3B6E1544-2A55-4BC0-B67A-37B2A034B22F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36946766-3B6E1544-2A55-4BC0-B67A-37B2A034B22F
Development of farnesyltransferase inhibitors for clinical cancer therapy: focus on hematologic malignancies.
P2860
Q36946766-3B6E1544-2A55-4BC0-B67A-37B2A034B22F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36946766-3B6E1544-2A55-4BC0-B67A-37B2A034B22F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
23e01565ba30f5f79e62d0d03d468af6423ed027
P2860
Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB.